{
  "event_id": "d208b0da1be7",
  "ticker": "SESN",
  "company_name": "Sesen Bio",
  "drug_name": "Vicineum",
  "pdufa_date": "2021-09-01",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:VISTA Phase 3 (CRL Aug 2021)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.608394",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "BCG-unresponsive NMIBC",
    "source": "websearch:VISTA Phase 3 (CRL Aug 2021)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.608395",
    "error": null
  },
  "generic_name": {
    "status": "not_searched",
    "value": null,
    "source": null,
    "confidence": 0.0,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "_reset_reason": "Was inferred from: final_mapping",
    "_reset_at": "2026-01-09T23:49:24.204703"
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Oncology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:59.071781",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "derived_from_result",
    "confidence": 0.95,
    "tier": 1,
    "searched_sources": [
      "result_field"
    ],
    "last_searched": null,
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": false,
    "source": "websearch:VISTA Phase 3 (CRL Aug 2021)",
    "confidence": 0.5,
    "evidence": [
      "VISTA Phase 3 (CRL Aug 2021)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.608381",
    "error": null
  },
  "p_value": {
    "status": "not_applicable",
    "value": null,
    "source": "websearch:VISTA Phase 3 (CRL Aug 2021)",
    "confidence": 0.9,
    "evidence": [
      "Single-arm or accelerated approval - no comparator p-value"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.608388",
    "error": null
  },
  "p_value_numeric": null,
  "effect_size": {
    "status": "found",
    "value": "CR 39% at 3 months",
    "source": "websearch:VISTA Phase 3 (CRL Aug 2021)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.608390",
    "error": null
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "phase3_study_names": [
    "Open-Label, Multicenter, Ph 3 [Phase 3] Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Subjects With Non Muscle-Invasive Carcinoma in Situ and/or High-Grade Papillary Disease of the Bladder Treated With BCG",
    "A Phase I Single-Arm Study of the Combination of Durvalumab (MEDI4736) and Vicineum (Oportuzumab Monatox, VB4-845) in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)",
    "Phase II Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Patients With Non-Invasive Urothelial Carcinoma in Situ (CIS) Previously Treated With Bacille Calmette-Guérin (BCG)"
  ],
  "nct_ids": [
    "NCT02449239",
    "NCT03258593",
    "NCT00462488"
  ],
  "enrollment": {
    "count": 133,
    "type": "ACTUAL",
    "nct_id": "NCT02449239",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:30:24.370350"
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "prior_crl_reason": {
    "status": "found",
    "value": "CMC issues from PAI + clinical data concerns",
    "source": "web_search",
    "category": "CMC_ISSUE",
    "confidence": 0.9,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 1,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.75,
    "tier": 2
  },
  "result": "crl",
  "data_quality_score": 0.15,
  "collected_at": "2026-01-09T00:33:38.587225",
  "enriched_at": "2026-01-11T20:15:03.530515",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "03507e228c41",
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "mechanism_of_action": "EpCAM-targeted immunotoxin",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": -1592,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:42.017536",
  "adcom_scheduled": {
    "value": false,
    "status": "confirmed_none",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:45:05.402014"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_applicable",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:45:05.402022"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:14:46.295282",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:14:51.704130",
    "search_status": "CONFIRMED_NONE"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Grants Priority Review to BLA for Vicineum for Treatment ... Vicineum (oportuzumab monatox-qqrs)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:14:52.849732",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Grants Priority Review to BLA for Vicineum for Treatment ... oportuzumab monatox Archives - The "
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:14:57.343243",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:15:03.530499",
    "search_status": "CONFIRMED_NONE"
  }
}